BioCryst Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in BioCryst Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $45M | 6.0M | 7.59 |
| 2025-06-30 | $50M | 5.6M | 8.96 |
| 2025-03-31 | $18M | 2.4M | 7.50 |
| 2024-12-31 | $1.9M | 248k | 7.52 |
| 2024-09-30 | $3.3M | 433k | 7.60 |
| 2024-06-30 | $2.5M | 400k | 6.18 |
| 2024-03-31 | $5.1M | 997k | 5.08 |
| 2023-12-31 | $4.1M | 685k | 5.99 |
| 2023-09-30 | $2.2M | 306k | 7.08 |
| 2023-06-30 | $3.1M | 442k | 7.04 |
| 2023-03-31 | $3.6M | 433k | 8.34 |
| 2022-12-31 | $7.4M | 646k | 11.48 |
| 2022-09-30 | $2.6M | 206k | 12.64 |
| 2022-06-30 | $1.6M | 152k | 10.30 |
| 2022-03-31 | $2.3M | 143k | 16.25 |
| 2021-12-31 | $7.4M | 533k | 13.85 |
| 2021-09-30 | $4.9M | 338k | 14.37 |
| 2021-06-30 | $2.9M | 179k | 16.18 |
| 2021-03-31 | $1.9M | 189k | 10.17 |
| 2020-12-31 | $3.9M | 528k | 7.46 |
| 2020-09-30 | $4.9M | 1.4M | 3.43 |
| 2020-06-30 | $757k | 159k | 4.77 |
| 2020-03-31 | $10M | 5.1M | 2.00 |
| 2019-12-31 | $19M | 5.5M | 3.45 |
| 2019-09-30 | $8.7M | 3.0M | 2.86 |
| 2019-06-30 | $8.4M | 2.2M | 3.80 |
| 2019-03-31 | $4.2M | 511k | 8.13 |
| 2018-12-31 | $1.0M | 126k | 8.07 |
| 2018-09-30 | $854k | 112k | 7.63 |
| 2018-06-30 | $362k | 63k | 5.72 |
| 2018-03-31 | $1.4M | 291k | 4.78 |
| 2017-12-31 | $493k | 100k | 4.92 |
| 2017-09-30 | $599k | 114k | 5.25 |
| 2017-06-30 | $353k | 64k | 5.56 |
| 2017-03-31 | $605k | 72k | 8.40 |
| 2016-12-31 | $632k | 100k | 6.33 |
| 2016-09-30 | $388k | 88k | 4.40 |
| 2016-06-30 | $241k | 84k | 2.86 |
| 2016-03-31 | $208k | 73k | 2.86 |
| 2015-12-31 | $1.5M | 146k | 10.32 |
| 2015-09-30 | $873k | 77k | 11.40 |
| 2015-03-31 | $688k | 74k | 9.29 |